Aeolus Pharmaceuticals’ AEOL 10150 Provides Significant Protection Of Lungs And Skin In Animal Studies Of Mustard Gas Exposure
Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) reported that researchers from National Jewish Research and Medical Center and the University of Colorado have completed a series of studies demonstrating that AEOL 10150 provides statistically significant protection of the lungs and skin in the 2-chloroethyl-ethylsulfide (CEES; half mustard) model of mustard gas exposure in rats.
This post is an original post by ScienceDaily: Skin Care News
Posted: April 25th, 2008 under skin health.
Comments: none
Write a comment